PATENT CLAIM ANALYSIS

Application Number: 15923275
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-09
Patent Classification: ["514", "005500"]

Abstract:
This invention relates to treating gastrointestinal dysfunction with erythropoietin (EPO) or its analog.

Claim (Index 3):
The method of  claim 2 , wherein the malnutrition-malabsorption problem is caused by one or more selected from the group consisting of an intestinal injury, an abdominal trauma, an intestinal inflammatory condition, an intestinal infection, constipation, post-operative ileus, a neurodegenerative injury, a neurotraumatic injury, a congenital problem, Gaucher disease, refeeding syndrome, extremely low birth weight infants, cancer cachexia, infection, cancer, spinal cord dysfunction, spinal dysraphism, bifida, tumor, central nervous system dysfunction, peripheral neuropathy, removal part of the gastrointestinal tract, hemorrhage, liver dysfunction, celiac disease, cystic fibrosis, muscular dystrophies, and cerebral palsy.

Metadata:
- Claim Count in Document: 47.0
- Percentile: 90.0
- Lexical Diversity: 1.0
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15136160', '13073275', '09717053', '15703457', '09716960']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7972887338738053
- 35 USC 102 Novelty (BERT): 0.5202626073277831
- Combined Prediction Score: 0.769586121219203
- Mean Citation Score: 210.323432
- Max Citation Score: 221.60922
- Similarity Product: 107.94162534282444

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test